Home Search

miti - search results

If you're not happy with the results, please do another search

Is David Dodd on to his Next Billion Dollar Payday for Shareholders?

Huge News: Gedeptin® Therapy Demonstrated Safety, Stabilization and Shrinkage of Treated Tumors. GeoVax (GOVX) Completes Patient...

Digital Coaches at Dario (DRIO) Significantly Reduce Depression.

63% of Users Show Significant Improvement After Impact of Digital Coaching and Breathing Exercises as Part of the Dario Health Platform.
DarioHealth,

Plansource Invites DarioHealth (DRIO) Into 50 Broker Partnership Network, Serving 5 Million Patients.

This looks like a coup for DarioHealth (DRIO), getting it's digital health solutions in front of more than 5 million new potential...

Adding Dario Health (DRIO) $2.81 to Watch List.

LIVE QUOTE Adding DarioHealth to Top Stocks of 2023...

Psycheceutical’s (BWVI) NeuroDirect™ Ketamine can Help Alleviate Headaches and Migraines Within Minutes, With no...

Photo MAPS Founder Rick Doblin visits Psycheceutical's Chief Visionary Officer Mike 'Zappy' Zapolin, CEO Chad Harman at the company's lab and tests...

The Next Generation Of Mental Health Treatment: Psycheceutical Bioscience Inc.’s Novel Topical Ketamine Delivery.

Psycheceutical Bioscience, Inc. Is Developing a Topical Application Of Ketamine Targeted to Relieve PTSD Symptoms Within Minutes and Negate Side Effects

Psycheceutical Bioscience Inc.’s (BWVI) Novel Topical Ketamine Delivery.

Rick Doblin, Recently Visited one of Psycheceutical's Labs. Psycheceutical Bioscience, Inc. Is Developing a Topical Application Of Ketamine Targeted...

We Warned About VERU (VERU) $2.50, Down 89%.

Down 35% Today, and 89% from $24, and a $1.9 Billion Market Cap, Only 7 Months ago. The FDA...
Roland Rick Perry

The Blood Sugar Trials.

Can a Swash Buckling Wall Street Analyst Lose Weight and get his Blood Sugar Down From Near 200 to Under 125?

Latest article

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!